These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 26770987)

  • 1. Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease.
    Oliveira CP; de Lima Sanches P; de Abreu-Silva EO; Marcadenti A
    J Diabetes Res; 2016; 2016():4597246. PubMed ID: 26770987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health benefits of Mediterranean diet in nonalcoholic fatty liver disease.
    Abenavoli L; Di Renzo L; Boccuto L; Alwardat N; Gratteri S; De Lorenzo A
    Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):873-881. PubMed ID: 30033779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
    Abenavoli L; Milic N; Peta V; Alfieri F; De Lorenzo A; Bellentani S
    World J Gastroenterol; 2014 Dec; 20(45):16831-40. PubMed ID: 25492997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
    Africa JA; Newton KP; Schwimmer JB
    Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.
    Saponaro C; Gaggini M; Gastaldelli A
    Curr Diab Rep; 2015 Jun; 15(6):607. PubMed ID: 25894944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease.
    Ordonez R; Carbajo-Pescador S; Mauriz JL; Gonzalez-Gallego J
    Curr Mol Med; 2015; 15(1):3-26. PubMed ID: 25601465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiography and NAFLD (non-alcoholic fatty liver disease).
    Trovato FM; Martines GF; Catalano D; Musumeci G; Pirri C; Trovato GM
    Int J Cardiol; 2016 Oct; 221():275-9. PubMed ID: 27404689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Dig Dis Sci; 2016 May; 61(5):1365-74. PubMed ID: 27052013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?
    Riazi K; Raman M; Taylor L; Swain MG; Shaheen AA
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31779112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.
    Marchisello S; Di Pino A; Scicali R; Urbano F; Piro S; Purrello F; Rabuazzo AM
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.
    Zivkovic AM; German JB; Sanyal AJ
    Am J Clin Nutr; 2007 Aug; 86(2):285-300. PubMed ID: 17684197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
    Ratziu V; Ghabril M; Romero-Gomez M; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):28-38. PubMed ID: 30300289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options.
    Milic S; Mikolasevic I; Krznaric-Zrnic I; Stanic M; Poropat G; Stimac D; Vlahovic-Palcevski V; Orlic L
    Drug Des Devel Ther; 2015; 9():4835-45. PubMed ID: 26316717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of NAFLD and Its Management.
    Mundi MS; Velapati S; Patel J; Kellogg TA; Abu Dayyeh BK; Hurt RT
    Nutr Clin Pract; 2020 Feb; 35(1):72-84. PubMed ID: 31840865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment.
    Kim KS; Lee BW; Kim YJ; Lee DH; Cha BS; Park CY
    Diabetes Metab J; 2019 Apr; 43(2):127-143. PubMed ID: 30993937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of diet and nutrient composition in nonalcoholic Fatty liver disease.
    McCarthy EM; Rinella ME
    J Acad Nutr Diet; 2012 Mar; 112(3):401-9. PubMed ID: 22717200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.